Recommendations for Advancing the Diagnosis and Management of Hereditary Breast and Ovarian Cancer in Brazil

被引:24
|
作者
Achatz, Maria Isabel [1 ]
Caleffi, Maira [2 ,3 ]
Guindalini, Rodrigo [4 ,5 ]
Marques, Renato Moretti [6 ,7 ]
Nogueira-Rodrigues, Angelica [8 ,9 ,10 ]
Ashton-Prolla, Patricia [11 ,12 ]
机构
[1] Hosp Sirio Libanes, Ctr Oncol, Sao Paulo, Brazil
[2] Nucleo Mama Porto Alegre, Porto Alegre, RS, Brazil
[3] Assoc Hosp Moinhos de Vento, Porto Alegre, RS, Brazil
[4] Rede DOr Sao Luiz, Oncol DOr, Rio De Janeiro, Brazil
[5] Univ Sao Paulo, Ctr Invest Translac Oncol, Inst Canc Estado Sao Paulo, Hosp Clin,Fac Med, Sao Paulo, Brazil
[6] Hosp Israelita Albert Einstein, Programa Saude Mulher, Sao Paulo, Brazil
[7] Hosp Israelita Albert Einstein, Ctr Oncol & Hematol, Sao Paulo, Brazil
[8] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil
[9] Grp Brasileiro Oncol Ginecol, Belo Horizonte, MG, Brazil
[10] DOM Oncol, Divinopolis, MG, Brazil
[11] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil
[12] Hosp Clin Porto Alegre, Lab Med Genom, Porto Alegre, RS, Brazil
关键词
BRCA MUTATION CARRIERS; NIPPLE-SPARING MASTECTOMY; COST-EFFECTIVENESS; HIGH-RISK; CONTRALATERAL MASTECTOMY; MAINTENANCE THERAPY; WOMEN; PANEL; TP53; SURVIVAL;
D O I
10.1200/JGO.19.00170
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSEThe objective of this review was to address the barriers limiting access to genetic cancer risk assessment and genetic testing for individuals with suspected hereditary breast and ovarian cancer (HBOC) through a review of the diagnosis and management steps of HBOC.METHODSA selected panel of Brazilian experts in fields related to HBOC was provided with a series of relevant questions to address before the multiday conference. During this conference, each narrative was discussed and edited by the entire group, through numerous drafts and rounds of discussion, until a consensus was achieved.RESULTSThe authors propose specific and realistic recommendations for improving access to early diagnosis, risk management, and cancer care of HBOC specific to Brazil. Moreover, in creating these recommendations, the authors strived to address all the barriers and impediments mentioned in this article.CONCLUSIONThere is a great need to expand hereditary cancer testing and counseling in Brazil, and changing current policies is essential to accomplishing this goal. Increased knowledge and awareness, together with regulatory actions to increase access to this technology, have the potential to improve patient care and prevention and treatment efforts for patients with cancer across the country. (c) 2020 by American Society of Clinical Oncology
引用
收藏
页码:439 / 452
页数:14
相关论文
共 50 条
  • [1] Genetic testing for hereditary breast and ovarian cancer and the USPSTF recommendations
    Wood, Marie E.
    Garber, Judy E.
    Isaacs, Claudine
    Masood, Shahla
    Bedrosian, Isabelle
    Tung, Nadine
    Chun, Jennifer
    Schnabel, Freya R.
    Arun, Banu K.
    BREAST JOURNAL, 2019, 25 (04) : 575 - 577
  • [2] Current Recommendations for the Prevention and Treatment of Hereditary Breast Cancer
    Kast, K.
    Distler, W.
    Schmutzler, R.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2010, 70 (08) : 634 - 639
  • [3] Considerations for hereditary breast and ovarian cancer syndrome molecular diagnosis: experience from the clinical practice
    Potrony, Miriam
    Morales-Romero, Blai
    Moreno, Lorena
    Pastor, Belen
    Grau, Elia
    Badenas, Celia
    Villanueva-Canas, Jose Luis
    Montalban-Casafont, Aina
    Arnau-Collell, Coral
    Ramon y Cajal, Teresa
    Manrique, Isabel Aragon
    Salas, Pilar Carrasco
    Puig, Susana
    Aguilera, Paula
    Alonso, Inmaculada
    Cebrecos, Isaac
    Gonzalez-Bosquet, Eduardo
    Mellado, Begona
    Ferrer-Mileo, Laura
    Rodriguez-Hernandez, Adela
    Prat, Aleix
    Munoz, Montserrat
    Gaba, Lydia
    Adamo, Barbara
    Oriola, Josep
    Sanchez, Aurora
    Puig-Butille, Joan Anton
    BREAST CANCER RESEARCH AND TREATMENT, 2025, : 507 - 519
  • [4] Hereditary breast and ovarian cancer
    Lax, S. F.
    PATHOLOGE, 2017, 38 (03): : 149 - 155
  • [5] Previvors' Uncertainty Management Strategies for Hereditary Breast and Ovarian Cancer
    Dean, Marleah
    Davidson, Lindy G.
    HEALTH COMMUNICATION, 2018, 33 (02) : 122 - 130
  • [6] Hereditary breast and ovarian cancer susceptibility genes
    Kobayashi, Hiroshi
    Ohno, Sumire
    Sasaki, Yoshikazu
    Matsuura, Miyuki
    ONCOLOGY REPORTS, 2013, 30 (03) : 1019 - 1029
  • [7] Hereditary Cancer Syndromesd-A Primer on Diagnosis and Management, Part 1: Breast-Ovarian Cancer Syndromes
    Samadder, N. Jewel
    Giridhar, Karthik V.
    Baffy, Noemi
    Riegert-Johnson, Douglas
    Couch, Fergus J.
    MAYO CLINIC PROCEEDINGS, 2019, 94 (06) : 1084 - 1098
  • [8] Imaging Recommendations for Diagnosis, Staging, and Management of Breast Cancer
    Thakur, Meenakshi
    Chakrabarthi, Suma
    Haria, Purvi
    Hari, Smriti
    Popat, Palak
    Katdare, Aparna
    Gala, Kunal
    Chouhan, Sonal
    Nair, Nita
    Bajpai, Jyoti
    Pathak, Rima
    Shet, Tanuja
    Mishra, Gauravi
    Shah, Sneha
    Joshi, Shalaka
    Mynalli, Soujanya
    Srikanth, Anne
    Kulkarni, Suyash
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2023, 44 (02) : 207 - 228
  • [9] Hereditary breast and ovarian cancer syndrome: Considering the complexities
    Senter, Leigha
    CURRENT PROBLEMS IN CANCER, 2014, 38 (06) : 226 - 234
  • [10] Pathology of Hereditary Breast and Ovarian Cancer
    Hodgson, Anjelica
    Turashvili, Gulisa
    FRONTIERS IN ONCOLOGY, 2020, 10